Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines, Genome-Wide Association Study of Susceptibility to RSV Hospitalization in Young Children <5 Years of Age, and Safety and Immunogenicity of XBB.1.5-containing mRNA Vaccines
Comments 0
Login to view comments.
Click here to Login
